SCHEMBL2706493

SCHEMBL2706493

CCCCCc1ccc(Nc2nc(-c3ccc(F)c(F)c3)cs2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
RAB9A P51151 3/20 0.48
PTGES O14684 2/20 0.48
ALOX5 P09917 5/20 0.48
PPARG P37231 1/20 0.48
PPARA Q07869 1/20 0.48
WNT3A P56704 1/20 0.46
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
PTGS2 P35354 2/20 0.45
NPC1 O15118 2/20 0.45
HPGDS O60760 1/20 0.45
PRMT5 O14744 1/20 0.45
WDR77 Q9BQA1 1/20 0.45
NPY5R Q15761 1/20 0.45
POLB P06746 1/20 0.45
GAA P10253 2/20 0.45
USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205925 0.87 ALOX5 (0.62) MEN1KMT2ARAB9AALOX5MAPT
SCHEMBL206235 0.86 ALOX5 (0.60) MEN1KMT2ARAB9AALOX5MAPT
SCHEMBL206863 0.86 ALOX5 (0.60) MEN1KMT2ARAB9AALOX5MAPT
SCHEMBL204772 0.86 SPHK1 (0.55) MEN1KMT2ARAB9AALOX5MAPT
SCHEMBL207407 0.85 ALOX5 (0.62) MEN1KMT2ARAB9AALOX5MAPT
SCHEMBL2706495 0.85 ALOX5 (0.55) MEN1KMT2ARAB9APTGESALOX5
SCHEMBL205369 0.84 ALOX5 (0.64) MEN1KMT2APTGESALOX5MAPT
SCHEMBL208369 0.84 ALOX5 (0.60) MEN1KMT2ARAB9AALOX5MAPT
SCHEMBL207687 0.84 ALOX5 (0.60) MEN1KMT2ARAB9AALOX5MAPT
SCHEMBL206705 0.84 ALOX5 (0.54) MEN1KMT2ARAB9APTGESALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 MEN1 3862/4885KMT2A 3476/4885RAB9A 1357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.